Advanced Glycation End Product 3 (AGE3) Increases Apoptosis and the Expression of Sclerostin by Stimulating TGF-β Expression and Secretion in Osteocyte-Like MLO-Y4-A2 Cells

MLA

Masakazu Notsu, et al. “Advanced Glycation End Product 3 (AGE3) Increases Apoptosis and the Expression of Sclerostin by Stimulating TGF-β Expression and Secretion in Osteocyte-Like MLO-Y4-A2 Cells.” Calcified Tissue International, vol. 100, Feb. 2017, pp. 402–11. EBSCOhost, https://doi.org/10.1007/s00223-017-0243-x.

APA

Masakazu Notsu, Ken-ichiro Tanaka, Ippei Kanazawa, Toshitsugu Sugimoto, Toru Yamaguchi, Maki Yokomoto-Umakoshi, & Ayumu Takeno. (2017). Advanced Glycation End Product 3 (AGE3) Increases Apoptosis and the Expression of Sclerostin by Stimulating TGF-β Expression and Secretion in Osteocyte-Like MLO-Y4-A2 Cells. Calcified Tissue International, 100, 402–411. https://doi.org/10.1007/s00223-017-0243-x

Chicago

Masakazu Notsu, Ken-ichiro Tanaka, Ippei Kanazawa, Toshitsugu Sugimoto, Toru Yamaguchi, Maki Yokomoto-Umakoshi, and Ayumu Takeno. 2017. “Advanced Glycation End Product 3 (AGE3) Increases Apoptosis and the Expression of Sclerostin by Stimulating TGF-β Expression and Secretion in Osteocyte-Like MLO-Y4-A2 Cells.” Calcified Tissue International 100 (February): 402–11. doi:10.1007/s00223-017-0243-x.